|
|
|
|
Vol. 57, Issue 2, 409-417, February 2000
Department of Pharmacology, Mayo Foundation for Medical Education
and Research and the Department of Research, Mayo Clinic Jacksonville,
Jacksonville, Florida (B.C., W.D.M., T.L.R.); and Laboratori de
Química Farmacèutica, Facultat de Farmàcia,
Universitat de Barcelona, Barcelona, Spain (P.C., R.E.A., J.M.,
D.M.-T.).
Inhibitors of the enzyme acetylcholinesterase (AChE) slow and sometimes
reverse the cognitive decline experienced by individuals with
Alzheimer's disease. Huperzine A, a natural product used in
traditional Chinese herbal medicine, and tacrine (Cognex) are among the
potent AChE inhibitors used in this treatment, but the search for more
selective inhibitors continues. We report herein the synthesis and
characterization of
(
)-12-amino-3-chloro-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline hydrochloride (huprine X), a hybrid that combines the carbobicyclic substructure of huperzine A with the 4-aminoquinoline substructure of
tacrine. Huprine X inhibited human AChE with an inhibition constant
KI of 26 pM, indicating that it binds to
this enzyme with one of the highest affinities yet reported. Under
equivalent assay conditions, this affinity was 180 times that of
huperzine A, 1200 times that of tacrine, and 40 times that of
E2020 (donepezil, Aricept), the most selective AChE inhibitor currently
approved for therapeutic use. The association and dissociation rate
constants for huprine X with AChE were determined, and the location of
its binding site on the enzyme was probed in competition studies with the peripheral site inhibitor propidium and the acylation site inhibitor edrophonium. Huprine X showed no detectable affinity for the
edrophonium-AChE complex. In contrast, huprine X did form a ternary
complex with propidium and AChE, although its affinity for the free
enzyme was found to be 17 times its affinity for the propidium-AChE
complex. These data indicated that huprine X binds to the enzyme
acylation site in the active site gorge but interferes slightly with
the binding of peripheral site ligands.
This article has been cited by other articles:
![]() |
J. J. Thomas, Z. Shen, J. E. Crowell, M. G. Finn, and G. Siuzdak Desorption/ionization on silicon (DIOS): A diverse mass spectrometry platform for protein characterization PNAS, April 5, 2001; (2001) 81069298. [Abstract] [Full Text] |
||||
![]() |
Z. Radic' and P. Taylor Interaction Kinetics of Reversible Inhibitors and Substrates with Acetylcholinesterase and Its Fasciculin 2 Complex J. Biol. Chem., February 9, 2001; 276(7): 4622 - 4633. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. De Ferrari, W. D. Mallender, N. C. Inestrosa, and T. L. Rosenberry Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase Peripheral Site That Reveals Conformational Interactions between the Peripheral and Acylation Sites J. Biol. Chem., June 22, 2001; 276(26): 23282 - 23287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Thomas, Z. Shen, J. E. Crowell, M. G. Finn, and G. Siuzdak Desorption/ionization on silicon (DIOS): A diverse mass spectrometry platform for protein characterization PNAS, April 24, 2001; 98(9): 4932 - 4937. [Abstract] [Full Text] [PDF] |
||||